GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Malaysian Genomics Resource Centre Bhd (XKLS:0155) » Definitions » Total Assets

Malaysian Genomics Resource Centre Bhd (XKLS:0155) Total Assets : RM24.69 Mil (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Malaysian Genomics Resource Centre Bhd Total Assets?

Malaysian Genomics Resource Centre Bhd's Total Assets for the quarter that ended in Mar. 2024 was RM24.69 Mil.

During the past 12 months, Malaysian Genomics Resource Centre Bhd's average Total Assets Growth Rate was -30.00% per year. During the past 3 years, the average Total Assets Growth Rate was -30.70% per year.

During the past 13 years, Malaysian Genomics Resource Centre Bhd's highest 3-Year average Total Assets Growth Rate was 40.70%. The lowest was -30.70%. And the median was 5.00%.

Total Assets is connected with ROA %. Malaysian Genomics Resource Centre Bhd's annualized ROA % for the quarter that ended in Mar. 2024 was -19.29%. Total Assets is also linked to Revenue through Asset Turnover. Malaysian Genomics Resource Centre Bhd's Asset Turnover for the quarter that ended in Mar. 2024 was 0.06.


Malaysian Genomics Resource Centre Bhd Total Assets Historical Data

The historical data trend for Malaysian Genomics Resource Centre Bhd's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Malaysian Genomics Resource Centre Bhd Total Assets Chart

Malaysian Genomics Resource Centre Bhd Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37.80 40.84 37.00 - 22.78

Malaysian Genomics Resource Centre Bhd Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 42.48 45.13 42.11 33.72 24.69

Malaysian Genomics Resource Centre Bhd Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Malaysian Genomics Resource Centre Bhd's Total Assets for the fiscal year that ended in Jun. 2021 is calculated as

Total Assets=Total Equity (A: Jun. 2021 )+Total Liabilities (A: Jun. 2021 )
=17.93+4.853
=22.78

Malaysian Genomics Resource Centre Bhd's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=20.591+4.094
=24.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Malaysian Genomics Resource Centre Bhd  (XKLS:0155) Total Assets Explanation

Total Assets is connected with ROA %.

Malaysian Genomics Resource Centre Bhd's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=-5.632/( (33.716+24.685)/ 2 )
=-5.632/29.2005
=-19.29 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Malaysian Genomics Resource Centre Bhd's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=1.774/( (33.716+24.685)/ 2 )
=1.774/29.2005
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Malaysian Genomics Resource Centre Bhd Total Assets Related Terms

Thank you for viewing the detailed overview of Malaysian Genomics Resource Centre Bhd's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Malaysian Genomics Resource Centre Bhd (XKLS:0155) Business Description

Traded in Other Exchanges
N/A
Address
8F, Jalan Teknologi 3/6, Taman Sains, Petaling Jaya, SGR, MYS, 47810
Malaysian Genomics Resource Centre Bhd is a Malaysia-based company engaged in providing laboratory services. It primarily offers genome sequencing and analysis (GSA) services, genetic screening services (GSS), and pathology services. GSA services involve the sequencing and analysis of the DNA of humans, animals, plants, and microbes, to discover meaningful biological information. The company is engaged in providing GSS by developing its own range of genetic screening tests under the brand Dtect which screen human DNA for genetic markers related to diseases and health conditions. It derives the majority of its revenue from Pathology services.

Malaysian Genomics Resource Centre Bhd (XKLS:0155) Headlines

No Headlines